Results showed that increased SPHK1 mRNA level could predict poorer overall survival than those patients with relatively low SPHK1 expression in GSE17538 dataset with 178 CRC samples and in TCGA database with 362 colorectal cancer patients involved (Fig. 4a). Here, SPHK1 is linked to colorectal carcinoma.